These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 32059920)

  • 1. Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases.
    Beaugerie L; Rahier JF; Kirchgesner J
    Clin Gastroenterol Hepatol; 2020 May; 18(6):1324-1335.e2. PubMed ID: 32059920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overall and Comparative Risk of Herpes Zoster With Pharmacotherapy for Inflammatory Bowel Diseases: A Nationwide Cohort Study.
    Khan N; Patel D; Trivedi C; Shah Y; Lichtenstein G; Lewis J; Yang YX
    Clin Gastroenterol Hepatol; 2018 Dec; 16(12):1919-1927.e3. PubMed ID: 29309905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients With Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.
    Singh S; Facciorusso A; Dulai PS; Jairath V; Sandborn WJ
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):69-81.e3. PubMed ID: 30876964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of systemic serious viral infections in patients with inflammatory bowel disease associates with active disease and use of thiopurines.
    Wisniewski A; Kirchgesner J; Seksik P; Landman C; Bourrier A; Nion-Larmurier I; Marteau P; Cosnes J; Sokol H; Beaugerie L;
    United European Gastroenterol J; 2020 Apr; 8(3):303-313. PubMed ID: 32529821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
    Côté-Daigneault J; Peerani F; MacMahon E; Delaporte E; Rahier JF; Colombel JF
    Inflamm Bowel Dis; 2016 Oct; 22(10):2538-47. PubMed ID: 27598743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
    Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
    J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases.
    Kirchgesner J; Lemaitre M; Carrat F; Zureik M; Carbonnel F; Dray-Spira R
    Gastroenterology; 2018 Aug; 155(2):337-346.e10. PubMed ID: 29655835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EBV Status and Thiopurine Use in Pediatric IBD.
    Gordon J; Ramaswami A; Beuttler M; Jossen J; Pittman N; Lai J; Dunkin D; Benkov K; Dubinsky M
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):711-4. PubMed ID: 26655944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr Virus Status and Subsequent Thiopurine Exposure Within a Paediatric Inflammatory Bowel Disease Population.
    Harris RE; Hegde V; Curtis L; Garrick V; Gervais L; Armstrong L; Delahunty C; Eccleston A; Al-Hourani G; Flynn DM; Merrick V; Barclay AR; Tayler R; Hansen R; Russell RK
    J Pediatr Gastroenterol Nutr; 2021 Sep; 73(3):358-362. PubMed ID: 34091548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus.
    Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ
    Intern Med J; 2017 Nov; 47(11):1263-1269. PubMed ID: 28516725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Epstein-Barr virus infection in patients with inflammatory bowel disease.
    Zhang H; Zhao S; Cao Z
    Front Immunol; 2022; 13():1001055. PubMed ID: 36389673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of herpes zoster among 108 604 patients with inflammatory bowel disease.
    Long MD; Martin C; Sandler RS; Kappelman MD
    Aliment Pharmacol Ther; 2013 Feb; 37(4):420-9. PubMed ID: 23240738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease.
    deBruyn JCC; Soon IS; Fonseca K; Feng S; Purtzki M; Goedhart C; Kuhn S; Vanderkooi OG; Wrobel I
    Inflamm Bowel Dis; 2019 Jun; 25(7):1218-1226. PubMed ID: 30551205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serious infections in patients with inflammatory bowel disease receiving anti-tumor-necrosis-factor-alpha therapy: an Australian and New Zealand experience.
    Lawrance IC; Radford-Smith GL; Bampton PA; Andrews JM; Tan PK; Croft A; Gearry RB; Florin TH
    J Gastroenterol Hepatol; 2010 Nov; 25(11):1732-8. PubMed ID: 21039834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines.
    Kopylov U; Levin A; Mendelson E; Dovrat S; Book M; Eliakim R; Ben-Horin S
    Aliment Pharmacol Ther; 2012 Jul; 36(2):145-50. PubMed ID: 22612376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canadian Association of Gastroenterology Clinical Practice Guideline for Immunizations in Patients With Inflammatory Bowel Disease (IBD)-Part 1: Live Vaccines.
    Benchimol EI; Tse F; Carroll MW; deBruyn JC; McNeil SA; Pham-Huy A; Seow CH; Barrett LL; Bessissow T; Carman N; Melmed GY; Vanderkooi OG; Marshall JK; Jones JL
    Gastroenterology; 2021 Aug; 161(2):669-680.e0. PubMed ID: 33617891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphoma and other lymphoproliferative disorders in inflammatory bowel disease: a review.
    Subramaniam K; D'Rozario J; Pavli P
    J Gastroenterol Hepatol; 2013 Jan; 28(1):24-30. PubMed ID: 23094824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Shukla T; Singh S; Tandon P; McCurdy JD
    J Clin Gastroenterol; 2017; 51(5):394-401. PubMed ID: 27875356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.